Ysios Capital launches fundraising efforts to pad its BioFund II lifesciences investment pool, planning on supporting up to 15 emerging companies in medtech, diagnostics and pharmaceuticals.
European venture capital firm Ysios Capital is looking to raise some $137.8 million (€100 million) in support of its lifesciences investment activities.
Ysios plans to use funds from the investment pool, which the company calls its BioFund II, to support up to 15 lifesciences companies with disruptive potential. The company in 2008 raised about $95 million (€69 million) for its BioFund I, according to a press release.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1l7DrWH
Cap comentari:
Publica un comentari a l'entrada